TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

interventional cardiology, cath lab videos
Feature | Cath Lab | March 07, 2017

Here is a compilation of some of DAIC's recent video coverage of new interventional cardiology device technologies...

Videos | Stents Bifurcation | March 06, 2017

This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent. It became the first...

tryton side branch stent, dedicated coronary side branch stent

The Tryton Side Branch Stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

Technology | Stents Bifurcation | March 06, 2017

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton...

CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra...

Claret Medical Sentinel Cerebral Protection System (CPS), FDA, TAVR embolic protection, transcatheter aortic valve replacement (TAVR).
News | Heart Valve Technology | February 28, 2017

February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...

transradial approach, same-day cardiac procedures, radial access, $300 million annual savings, JACC Cardiovascular Interventions study
News | Radial Access | February 22, 2017

February 22, 2017 — If hospitals can perform more...

heart team, hybird OR, structural heart team

The heart team approach was first used on a large scale in the CoreValve and Sapien TAVR trials and helped lead to excellent outcomes in high-risk patients.

Feature | Hybrid OR | February 15, 2017 | Dave Fornell

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve...

Blog | Stents | February 13, 2017

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...

 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.

The Corvia Intra-atrial shunt device (IASD) lowers left atrial pressure by creating a small left atrial to right atrial shunt. Preliminary clinical studies have shown promise for these types of devices to improve HFpEF patient outcomes.

Feature | Heart Failure | February 10, 2017 | Dave Fornell

In the past few years there have been a number of device therapies developed to treat...

Blog | January 30, 2017

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...

Tendyne Mitral valve

The Tendyne mitral valve being implanted. 

News | Heart Valve Technology | January 16, 2017

January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the...

OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017

January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

Overlay Init